Neopterin production, degradation of tryptophan and neurologic impairment in human immunodeficiency virus infection

Pteridines

Volumn 7, Issue 1, 1996, Pages 29-34

  Diez Ruiz, Antonio ^a,c   Möller, Arnulf A ^b   Baier Bitterlich, Gabriele ^a   Wachter, Helmut ^a   Fuchs, Dietmar ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c U of Granada   (Spain)

Author keywords

Brain; HIV infection; Immune activation; Interferon ; Neopterin; Tryptophan

Indexed keywords

GAMMA INTERFERON; KYNURENINE; NEOPTERIN; TRYPTOPHAN;

ADULT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; MALE; MENTAL HEALTH; MENTAL TEST; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029994901     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.1996.7.12.29     Document Type: Review

References (24)

1. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988; 239: 617.
2. Morrow WJW, Isemberg DA, Sobol RE, Stricker RB, Kieber Emmons T. AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol 1991; 58: 163-180.
3. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Interferon gamma concentrations are increased in sera from individuals infected with human immunodficiency virus type I. J Acquir Immune Defic Syndr 1989; 2: 158-162.
4. Fuchs D, Chiodi F, Albert J, AsjöB, Hagberg L, Hausen A, Norkrans G, Reibnegger G, Werner ER, Wachter H. Neopterin concentrations in cerebrospinal fluid of individuals infected with HIV-1. AIDS 1989; 3: 285-288.
5. Tyor WR, Glass JD, Baumrind N, McArthur JC; Griffin JW; BeckerPS, Griffin DE. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 1993; 43: 1002-1009.
6. Achim CL, Heyes MP, Wiley CA. Quantitation of human immunodeficiency virus immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 1993; 91: 2769-2775.
7. Larsson M, Hagberg L, Norkrans G, Forsman A. Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J Neurosci Res 1989; 23: 441-446.
8. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/ psychiatric symptoms. J Acquir Immune Defic Syndr 1990; 3: 873-876.
9. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, Rubinow D, Markey SP. Quinolinic acid in the cerebrospinal fluid an serum in HIV-1 infection: Relationship to clinical and neurological status. Ann Neurol 1991; 29: 202-209.
10. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res 1990; 50: 2863-2867.
11. Heyes MP, Saito K, Markey SP. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J 1992; 283: 633-635.
12. Redfield RR, Wright DC, Tramont EC. The Walter-Reed Staging classification for HTLV III/LAV in- fection. New Engl J Med 1986; 314: 131-132.
13. Zaudig M, Mittelhammer J, Hiller W, Pauls A, Thora C, Moringo A, Mombour W. Description and test-retest reliability of the SIDAM- A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other etiology according to ICD-10 and DSM-III- R. Psychol Med 1991; 21: 225-236.
14. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D. Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 1993; 168: 1285-1288.
15. Gasse T, Murr C, Meyersbach P, Schmutzhard E, Wachter H, Fuchs D. Neopterin production and tryptophan degradation in acuta Lyme neuroborreliosis versus late Lyme encephalopathy. Eur J Clin Chem Clin Biochem 1994; 32: 685-689.
16. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: Immunologic basis and clinical application. Adv Clin Chem 1989; 27: 81-141.
17. Zangerle R, Gallati H, Sarcletti M, Weiss G, Denz H, Wachter H, Fuchs D. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associared with immune activation. J Acquir Immune Defic Syndr 1994; 7: 79-85.
18. Diez-Ruiz A, Tilz GP, Zangerle R, Baier Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1-8.
19. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection. Immunol Today 1988; 9: 150-155.
20. Rudzite V, Skards JI, Fuchs D, Reibnegger G, Wachter H. Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. Immunol Lett 1992; 32: 125-130.
21. Fuchs D, Muller AA, Reibnegger G, Werner ER, Werner-Felmaver G, Dierich MP, Wachter H. In- creased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficieny virus infection. Immunol Lett 1991; 28: 207-212.
22. Ott M, Demisch L, Engelhardt W, Fischer PA. Intcrleukin-2, soluble interleukin-2 receptor, neopterin, L-tryptophan and β2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic progressive multiple sclerosis. J Neurol 1993; 241: 108-114.
23. Moeller AA, Fuchs D, Reibnegger G, Zaudig M, Werner ER, Wachter H. Changes of neopterin and tryptophan in serum and cerebrospinal fluid of patients in different stages of HIV-1 infection. Pteridines 1990; 2: 91-93.
24. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Semenitz E, Dierich MP, Wachter H. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett 1993; 1: 89-92.